Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aidan Synnott
CEO | Chief Executive Officer | 48 | 10/04/2025 |
Fabrice Viviani
CEO | Chief Executive Officer | - | 04/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 23/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 13/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 02/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 23/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 24/10/22 | Sell | Chief Technology Officer | 17,640 | 0.2576% | ||
| 24/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -0.14% | - | - | 105M | ||
| -1.78% | -1.68% | +1.99% | +13.84% | 48.42B | ||
| +0.85% | -0.70% | +465.55% | +579.03% | 43.66B | ||
| -2.40% | -0.23% | +12.20% | +70.22% | 39.51B | ||
| -2.01% | -0.85% | +24.95% | +7.51% | 38.95B | ||
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | ||
| -0.59% | -2.06% | +26.13% | +117.79% | 16.15B | ||
| +0.38% | -3.23% | - | - | 16.32B | ||
| +0.49% | +0.92% | +4.32% | +22.16% | 14.16B | ||
| -0.43% | +4.70% | +79.75% | +29.11% | 13.37B | ||
| Average | -0.60% | +0.49% | +79.44% | +111.17% | 29.24B | |
| Weighted average by Cap. | -0.91% | +0.59% | +97.63% | +134.68% |
Employees
236
















